Hims & Hers Health vs LifeMD
HIMS and LFMD side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HIMS and LFMD compare
Hims & Hers Health is the larger company, worth 57 times as much as LifeMD ($4.9B against $85.8M).
Hims & Hers Health grew revenue faster over the last twelve months (29.8% versus 3.8% for LifeMD).
LifeMD keeps more of each dollar of sales as profit, with a net margin of 0.12% compared with −6.7% at Hims & Hers Health.
LifeMD scores higher on the StockData Score (12 against 8 for Hims & Hers Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HIMS | LFMD |
|---|---|---|
| Size and price | ||
| Market cap | $4.9B | $85.8M |
| Share price | $20.81 | $1.78 |
| Change, 1 year | −49.3% | −65.3% |
| Change, 5 years | 185% | −60.8% |
| Beta (5Y) | 2.05 | 1.71 |
| Employees | 1,046 | 389 |
| StockData Score | ||
| Total score | 8 | 12 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 3 | 3 |
| Performance score | 1 | 3 (better) |
| Health score | 4 | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.7× | 0.5× (better) |
| P/B | 13.7× | 10.8× (better) |
| P/FCF | 591× | – |
| FCF yield | 0.17% (better) | −12.9% |
| Fair value | $6.83 | $2.38 |
| Margin of safety | −205% | 25.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 29.8% (better) | 3.8% |
| Revenue growth, 5Y average | 73.6% (better) | 39.1% |
| Net income growth (TTM) | −243% | – |
| EPS growth (TTM) | −254% | – |
| Profitability | ||
| Gross margin | 63.8% | 86.1% (better) |
| Operating margin | −8.1% (better) | −14.7% |
| Net margin | −6.7% | 0.12% (better) |
| FCF margin | 0.29% (better) | −6.7% |
| Return on equity | −40.8% | 6.5% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 0.92 (better) | 0.90 |
| Altman Z-score | 1.34 (better) | −3.44 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Payout ratio | – | 1545% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 67.1% | 44.9% |
| Held by insiders | 10.9% | 18.2% |
| Insider net buying, 12 months | −$17.1M | −$54.1K (better) |
| Short interest, % of float | 24.9% | – |
Go deeper
- HIMS stock overview
- HIMS income statement
- HIMS valuation and score
- LFMD stock overview
- LFMD income statement
- LFMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.